U

nited Health Group (UNH), the nation’s largest health insurer, has suddenly ended a controversial policy that restricted access to an HIV prevention drug, which could only be obtained after patients completed enrollment forms asking about high-risk sexual behavior.

Last Friday, more than a dozen AIDS advocacy groups sent a letter accusing the insurer of violating federal law for requiring beneficiaries to disclose whether they had engaged in high-risk homosexual, heterosexual, or bisexual behavior. Plan members were required to respond to obtain Truvada, which is also known as Pre-Exposure Prophylaxis, or PrEP, a pill sold by Gilead Sciences (GILD). And they had to deal with a United Health mail order pharmacy.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • Truvada is just a combo drug. Why not just get a prescription for the two different drugs if you’ve run out? Hopefully UHC will cover them as separate drugs and your co-pay is not so high. Retail wish Emtricitabine + Tenofovir is about the same price as Truvada ($1500 / 30 pills)

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy